Severe Myoclonic Epilepsy in Infancy: Toward an Optimal Treatment
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Severe myoclonic epilepsy in infancy, or Dravet syndrome, is one of the catastrophic epilepsy syndromes. In the past, treatment was mainly based on valproate and phenobarbital. Recently, some of the new antiepilepsy drugs, such as topiramate and stiripentol, have been shown to be promising in the treatment of this epilepsy syndrome. The treatment regimen of 12 children with Dravet syndrome and proven mutations in the alpha subunit of the sodium channel SCN1A is reported here. Five patients on the “traditional” treatment regimen are compared with seven children on an “optimal” treatment regimen based on a combination of valproate and topiramate. With respect to the literature and our own experience, we propose guidelines for “optimal” treatment of children with severe myoclonic epilepsy in infancy. This includes prevention of hyperthermia, rigorous treatment of fever, avoiding stressful situations, maintenance treatment based on a combination of only two antiepilepsy drugs (ie, valproate and topiramate), and a strict acute seizure treatment based on benzodiazepines. To prevent long-lasting periods of status epilepticus, this acute seizure treatment must be taught to parents and caregivers. ( J Child Neurol 2004;19:516—521).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
De Novo Mutations in the Sodium-Channel Gene SCN1A Cause Severe Myoclonic Epilepsy of Infancy
Claes, L., Del-Favero, J., Ceulemans, B., Lagae, L., Van Broeckhoven, C., & De Jonghe, P. (2001) · The American Journal of Human Genetics · doi:10.1086/320609 · Cited by 1,292
Self-citationChiron, C., Marchand, M., Tran, A., Rey, E., d'Athis, P., Vincent, J., Dulac, O., & Pons, G. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03157-3 · Cited by 568
Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy
Guerrini, R., Dravet, C., Genton, P., Belmonte, A., Kaminska, A., & Dulac†, O. (1998) · Epilepsia · doi:10.1111/j.1528-1157.1998.tb01413.x · Cited by 467
Stiripentol: Efficacy and Tolerability in Children with Epilepsy
Perez, J., Chiron, C., Musial, C., Rey, E., Blehaut, H., D'Athis, P., Vincent, J., & Dulac, O. (1999) · Epilepsia · doi:10.1111/j.1528-1157.1999.tb02048.x · Cited by 148
Fişgin, T., Gurer, Y., Tezic, T., Senbil, N., Zorlu, P., Okuyaz, C., & Akgün, D. (2002) · Journal of Child Neurology · doi:10.1177/088307380201700206 · Cited by 138
Cited by
Yu, F. H., Mantegazza, M., Westenbroek, R. E., Robbins, C. A., Kalume, F., Burton, K. A., Spain, W. J., McKnight, G. S., Scheuer, T., & Catterall, W. A. (2006) · Nature Neuroscience · doi:10.1038/nn1754 · Cited by 1,173
“and has recently been recommended as a preferred chronic therapy in combination with valproat”
BackgroundPrognostic, clinical and demographic features in SCN1A mutation-positive Dravet syndrome
Brunklaus, A., Ellis, R., Reavey, E., Forbes, G. H., & Zuberi, S. M. (2012) · Brain · doi:10.1093/brain/aws151 · Cited by 366
“There is evidence from several open label and retrospective studies that topiramate is useful in Dravet syndrome, however, no randomized controlled trials have been performed yet (Nieto-Barrera et al., 2000; Ceulemans et al., 2004; Kröll-Seger et al., 2006).”
BackgroundIncidence of Dravet Syndrome in a US Population
Wu, Y. W., Sullivan, J., McDaniel, S. S., Meisler, M. H., Walsh, E. M., Li, S. X., & Kuzniewicz, M. W. (2015) · Pediatrics · doi:10.1542/peds.2015-1807 · Cited by 248
“8 Language delay, autism 3 Yes 4 Myoclonic, focal 2 2 Normal (9) 5.”
Successful use of fenfluramine as an add‐on treatment for Dravet syndrome
Ceulemans, B., Boel, M., Leyssens, K., Van Rossem, C., Neels, P., Jorens, P. G., & Lagae, L. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03495.x · Cited by 210
“Other authors have proposed sodium valproate in combination with topiramate with or without benzodiazepines to be an effective maintenance treatment for Dravet syndrome (Nieto-Barrera et al., 2000; Coppola et al., 2002; Ceulemans et al., 2004; Kroll-Seger et al., 2006).”
BackgroundSelf-citation
Metadata
- Authors
- Ceulemans, B., Boel, M., Claes, L., Dom, L., Willekens, H., Thiry, P., & Lagae, L.
- Venue
- Journal of Child Neurology
- Publisher
- SAGE Publications
- Published
- 2004-07
- Volume
- 19
- Issue
- 7
- Pages
- 516-521
- ISSN
- 0883-0738 (ISSN-L)
- 1708-8283
- OpenAlex
- W2012671124
- Cited by
- 59
- References
- 5
- FWCI
- 1.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severe Myoclonic Epilepsy in Infancy: Toward an Optimal Treatment. https://app.cochat.ai/papers/10.1177/08830738040190070701
- The paper
- Ceulemans, B., Boel, M., Claes, L., Dom, L., Willekens, H., Thiry, P., & Lagae, L. (2004). Severe Myoclonic Epilepsy in Infancy: Toward an Optimal Treatment. Journal of Child Neurology. https://doi.org/10.1177/08830738040190070701
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.